Antithymocyte globulin - or alemtuzumab-based gvhd prophylaxis in reduced- intensity conditioning allo-hct for acute lymphoblastic leukemia in cr1: a study from the acute leukemia working party

BONE MARROW TRANSPLANTATION(2023)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要